These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 32106499)
1. Should We Consider the Cardiovascular System While Evaluating CKD-MBD? Rroji M; Figurek A; Spasovski G Toxins (Basel); 2020 Feb; 12(3):. PubMed ID: 32106499 [TBL] [Abstract][Full Text] [Related]
2. Role of Chronic Kidney Disease (CKD)-Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD. Yamada S; Nakano T J Atheroscler Thromb; 2023 Aug; 30(8):835-850. PubMed ID: 37258233 [TBL] [Abstract][Full Text] [Related]
3. Association between CKD-MBD and mortality in older patients with advanced CKD-results from the EQUAL study. Magagnoli L; Cozzolino M; Caskey FJ; Evans M; Torino C; Porto G; Szymczak M; Krajewska M; Drechsler C; Stenvinkel P; Pippias M; Dekker FW; de Rooij ENM; Wanner C; Chesnaye NC; Jager KJ; Nephrol Dial Transplant; 2023 Oct; 38(11):2562-2575. PubMed ID: 37230954 [TBL] [Abstract][Full Text] [Related]
4. Klotho-FGF23, Cardiovascular Disease, and Vascular Calcification: Black or White? Cianciolo G; Galassi A; Capelli I; Schillaci R; La Manna G; Cozzolino M Curr Vasc Pharmacol; 2018 Jan; 16(2):143-156. PubMed ID: 28294047 [TBL] [Abstract][Full Text] [Related]
5. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho. Yamada S; Giachelli CM Bone; 2017 Jul; 100():87-93. PubMed ID: 27847254 [TBL] [Abstract][Full Text] [Related]
6. Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD. Behets GJ; Viaene L; Meijers B; Blocki F; Brandenburg VM; Verhulst A; D'Haese PC; Evenepoel P PLoS One; 2017; 12(5):e0176411. PubMed ID: 28493902 [TBL] [Abstract][Full Text] [Related]
7. Mineral metabolism and cardiovascular disease in CKD. Fujii H; Joki N Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):53-63. PubMed ID: 28062938 [TBL] [Abstract][Full Text] [Related]
8. Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications. Kaur R; Singh R Life Sci; 2022 Dec; 311(Pt B):121148. PubMed ID: 36336124 [TBL] [Abstract][Full Text] [Related]
9. The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology. Hruska KA; Sugatani T; Agapova O; Fang Y Bone; 2017 Jul; 100():80-86. PubMed ID: 28119179 [TBL] [Abstract][Full Text] [Related]
10. [CKD-MBD and cardiovascular disease.]. Fujii H Clin Calcium; 2019; 29(2):179-184. PubMed ID: 30679398 [TBL] [Abstract][Full Text] [Related]
11. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification. Bover J; Ureña-Torres P; Lloret MJ; Ruiz-García C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J Expert Opin Pharmacother; 2016 Jun; 17(9):1247-58. PubMed ID: 27156993 [TBL] [Abstract][Full Text] [Related]
12. Sclerostin: a new biomarker of CKD-MBD. Figurek A; Rroji M; Spasovski G Int Urol Nephrol; 2020 Jan; 52(1):107-113. PubMed ID: 31612420 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD). Hruska KA; Choi ET; Memon I; Davis TK; Mathew S Pediatr Nephrol; 2010 Apr; 25(4):769-78. PubMed ID: 19898875 [TBL] [Abstract][Full Text] [Related]
14. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation. Pimentel A; Ureña-Torres P; Zillikens MC; Bover J; Cohen-Solal M Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571 [TBL] [Abstract][Full Text] [Related]
15. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis. Koizumi M; Komaba H; Fukagawa M Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554 [TBL] [Abstract][Full Text] [Related]
16. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome]. Hu S; Wang D; Zhang R; Cao Y; Jin H; Mao Y; Wei L; Ren K; Zhang X; Wang Y Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1427-1432. PubMed ID: 30613009 [TBL] [Abstract][Full Text] [Related]
17. Phosphate and bone fracture risk in chronic kidney disease patients. Fusaro M; Holden R; Lok C; Iervasi G; Plebani M; Aghi A; Gallieni M; Cozzolino M Nephrol Dial Transplant; 2021 Feb; 36(3):405-412. PubMed ID: 31620773 [TBL] [Abstract][Full Text] [Related]
18. Histomorphometric diagnostics of renal osteopathy in chronic dialysis patients at high risk of cardiovascular disease. Žamboch K; Krejčí K; Škarda J; Tichý M; Überall I; Skýpalová P; Langová K; Stejskal D; Švesták M; Zahálková J; Ščudla V; Zadražil J Int Urol Nephrol; 2015 Jul; 47(7):1195-201. PubMed ID: 25931273 [TBL] [Abstract][Full Text] [Related]
19. Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder. Sugatani T Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142896 [TBL] [Abstract][Full Text] [Related]
20. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)]. Omata M; Fukagawa M; Kakuta T Clin Calcium; 2015 May; 25(5):645-53. PubMed ID: 25926567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]